We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$3.73B
AUM Growth
+$36.2M
(+0.98%)
Cap. Flow
-$5.17M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
11.3%
Holding
1,547
New
510
Increased
264
Reduced
248
Closed
521
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$45.4M |
| 2 |
Qualcomm
QCOM
|
+$44.3M |
| 3 |
Union Pacific
UNP
|
+$41.1M |
| 4 |
eBay
EBAY
|
+$40.2M |
| 5 |
Baxter International
BAX
|
+$36.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$42M |
| 2 |
CELG
Celgene Corp
CELG
|
+$41.2M |
| 3 |
Goldman Sachs
GS
|
+$39.5M |
| 4 |
Honeywell
HON
|
+$37M |
| 5 |
FedEx
FDX
|
+$34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.67% |
| 2 | Industrials | 14.62% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Energy | 10.18% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
IAMGOLD
IAG
$8.21B
| $172K | ﹤0.01% |
+41,793
| New | +$149K |
|
952
Sumitomo Mitsui Financial
SMFG
$163B
| $171K | ﹤0.01% |
20,213
-33,565
| -62% | -$277K |
|
953
Neurocrine Biosciences
NBIX
$18.2B
| $170K | ﹤0.01% |
+11,481
| New | +$162K |
|
|
CDR
954
DELISTED
Cedar Realty Trust, Inc
CDR
| $168K | ﹤0.01% |
+4,073
| New | +$164K |
|
|
JRN
955
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $160K | ﹤0.01% |
17,990
+931
| +5% | +$7.69K |
|
|
GLDD
956
DELISTED
Great Lakes Dredge & Dock
GLDD
| $159K | ﹤0.01% |
19,915
+8,570
| +76% | +$69.9K |
|
|
ACHN
957
DELISTED
Achillion Pharmaceuticals
ACHN
| $158K | ﹤0.01% |
+20,856
| New | +$83.2K |
|
|
PDLI
958
DELISTED
PDL BioPharma, Inc.
PDLI
| $158K | ﹤0.01% |
+16,305
| New | +$145K |
|
|
BLOX
959
DELISTED
Infoblox Inc
BLOX
| $157K | ﹤0.01% |
11,955
-8,323
| -41% | -$142K |
|
960
Talphera
TLPH
$64.9M
| $156K | ﹤0.01% |
+760
| New | +$152K |
|
|
PIKE
961
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
| $156K | ﹤0.01% |
17,409
+2,289
| +15% | +$21.4K |
|
962
Walker & Dunlop
WD
$1.73B
| $154K | ﹤0.01% |
+10,942
| New | +$167K |
|
963
Alaunos Therapeutics
TCRT
$4.57M
| $153K | ﹤0.01% |
253
+159
| +169% | +$88.5K |
|
|
SEAC
964
DELISTED
Seachange International Inc
SEAC
| $153K | ﹤0.01% |
956
-237
| -20% | -$43.5K |
|
|
CARB
965
DELISTED
Carbonite Inc
CARB
| $152K | ﹤0.01% |
12,672
-884
| -7% | -$9.14K |
|
|
ACI
966
DELISTED
ARCH COAL, INC.
ACI
| $150K | ﹤0.01% |
4,105
+2,007
| +96% | +$83.2K |
|
967
Star Bulk Carriers
SBLK
$3.09B
| $149K | ﹤0.01% |
+2,295
| New | +$141K |
|
968
StealthGas
GASS
$331M
| $148K | ﹤0.01% |
+13,326
| New | +$143K |
|
969
TransAlta
TAC
$4.04B
| $148K | ﹤0.01% |
+12,037
| New | +$144K |
|
970
Entegris
ENTG
$18.2B
| $147K | ﹤0.01% |
10,685
-52,820
| -83% | -$627K |
|
971
Enphase Energy
ENPH
$4.79B
| $146K | ﹤0.01% |
+17,105
| New | +$139K |
|
972
Opko Health
OPK
$1.25B
| $146K | ﹤0.01% |
+16,479
| New | +$144K |
|
973
Verastem
VSTM
$541M
| $144K | ﹤0.01% |
1,325
-43
| -3% | -$4.68K |
|
|
CPE
974
DELISTED
Callon Petroleum Company
CPE
| $144K | ﹤0.01% |
1,235
-1,411
| -53% | -$140K |
|
975
TTM Technologies
TTMI
$11.2B
| $140K | ﹤0.01% |
17,087
-14,823
| -46% | -$116K |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Stevens Capital Management held 1,547 positions worth $3.73B, up 0.98% from $3.69B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Stevens Capital Management's Q2 2014 filing shows 510 new, 264 increased, 248 reduced and 521 closed positions. Its largest new stake was Pfizer: 1,593,770 shares worth $44.9M. The largest sale was Chevron, an estimated $42M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Stevens Capital Management's largest Q2 2014 buy was Pfizer: 1,593,770 shares worth $44.9M.
- Stevens Capital Management added most to ExxonMobil in Q2 2014, an estimated $34.2M increase.
- Stevens Capital Management's biggest Q2 2014 reduction was FedEx, cutting an estimated $34M.
- Stevens Capital Management fully exited Chevron in Q2 2014, selling an estimated $42M.
- Stevens Capital Management's ten largest holdings make up 11% of its $3.73B portfolio in Q2 2014.
- Stevens Capital Management opened 510 new positions and closed 521 in Q2 2014.
- Stevens Capital Management's portfolio value rose 0.98% quarter-over-quarter to $3.73B.
Based on Stevens Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.